Evidence map›Paper›PMID 31523512›Full record

ArticlePeerJ2019

HiLDA: a statistical approach to investigate differences in mutational signatures.

Zhi Yang, Priyatama Pandey, Darryl Shibata, David V Conti, Paul Marjoram, Kimberly D Siegmund

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Diffsig: Associating Risk Factors with Mutational Signatures.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  3. Mutational Signatures: From Methods to Mechanisms.Annual review of biomedical data science · 2021
    Article
  4. F1000Research · 2020
    Article
  5. Mutational signatures in colon cancer.BMC research notes · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zhi YangDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Priyatama PandeyDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Darryl ShibataDepartment of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
David V ContiDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Paul MarjoramDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Kimberly D SiegmundDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
University of Southern California · US

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MYLES G COCKBURN · 1985 to 2026
$181.4M
Statistical Methods for Integrative Genomics in CancerP01CA196569 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Paul Marjoram · 2016 to 2026
$25.5M
The Role of the Microbiome in Cancer Suppression and Susceptibility Across SpeciesU54CA217376 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MALEY, CARLO · 2018 to 2022
$8.6M
NCI NIH HHS P01 CA196569NCI NIH HHS P30 CA014089NCI NIH HHS U54 CA217376
6 · The paper itself

Abstract

We propose a hierarchical latent Dirichlet allocation model (HiLDA) for characterizing somatic mutation data in cancer. The method allows us to infer mutational patterns and their relative frequencies in a set of tumor mutational catalogs and to compare the estimated frequencies between tumor sets. We apply our method to two datasets, one containing somatic mutations in colon cancer by the time of occurrence, before or after tumor initiation, and the second containing somatic mutations in esophageal cancer by sex, age, smoking status, and tumor site. In colon cancer, the relative frequencies of mutational patterns were found significantly associated with the time of occurrence of mutations. In esophageal cancer, the relative frequencies were significantly associated with the tumor site. Our novel method provides higher statistical power for detecting differences in mutational signatures.

Indexed as

Colorectal cancerDeconvolutionLatent dirichlet allocationMutational signaturesSomatic mutation

Identifiers

PMID31523512
PMCPMC6717498
OpenAlexW2970457274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.